Elke Weisshaar Selected Research

Elke Weisshaar Research Topics

Disease

22	Pruritus (Itching) 10/2022 - 02/2003
14	Hypersensitivity (Allergy) 10/2022 - 05/2008
12	Eczema 06/2023 - 05/2006
11	Contact Dermatitis (Eczema, Contact) 06/2023 - 01/2005
8	Atopic Dermatitis (Atopic Eczema) 03/2024 - 07/2003
6	Skin Diseases (Skin Disease) 06/2023 - 01/2005
6	Dermatitis 01/2023 - 06/2006
5	Prurigo 09/2023 - 06/2006
4	Allergic Contact Dermatitis 06/2023 - 01/2005
3	Pain (Aches) 12/2016 - 06/2011
2	Occupational Diseases (Occupational Disease) 01/2021 - 05/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024
1	Hand Dermatoses 03/2024
1	Inflammation (Inflammations) 01/2023
1	Occupational Dermatitis 01/2023
1	Disease Susceptibility (Diathesis) 01/2021
1	Nasopharyngitis 05/2019
1	Diarrhea 05/2019
1	Fatigue 05/2019
1	Headache (Headaches) 01/2019
1	Sleepiness 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2015
1	Chronic Renal Insufficiency 02/2010
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 01/2010
1	Amyloidosis 01/2009
1	Neuralgia (Stump Neuralgia) 03/2008
1	Acrodermatitis (Gianotti Crosti Syndrome) 06/2007

Drug/Important Bio-Agent (IBA)

13	AllergensIBA 06/2023 - 04/2009
8	AntipruriticsIBA 10/2022 - 05/2004
7	Irritants (Vesicants)IBA 03/2021 - 01/2005
6	Histamine Antagonists (Antihistamines)IBA 01/2019 - 05/2004
3	NickelIBA 02/2021 - 05/2008
3	Histamine (Histamine Dihydrochloride)FDA Link 05/2004 - 05/2003
2	Thiram FDA Link 06/2023 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2019
2	dupilumabIBA 01/2023 - 12/2022
2	Peruvian balsam (balsam of Peru)IBA 02/2021 - 06/2009
2	HaptensIBA 02/2021 - 06/2018
2	2-methyl-4-isothiazolin-3-oneIBA 02/2021 - 01/2021
2	Cetirizine (Zyrtec)FDA LinkGeneric 01/2019 - 05/2004
2	Antidepressive Agents (Antidepressants)IBA 09/2012 - 03/2008
2	Serotonin (5 Hydroxytryptamine)IBA 05/2004 - 07/2003
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	CarbamatesIBA 06/2023
1	Prostaglandins AIBA 01/2023
1	Volatile Oils (Essential Oils)IBA 01/2023
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023
1	Formaldehyde (Formol)FDA Link 02/2021
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2021
1	ChromiumIBA 01/2021
1	5-chloro-2-methyl-4-isothiazolin-3-oneIBA 01/2021
1	CobaltIBA 01/2021
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 05/2019
1	serlopitantIBA 05/2019
1	Neurokinin-1 Receptor AntagonistsIBA 05/2019
1	fexofenadine (Allegra)FDA LinkGeneric 01/2019
1	hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric 01/2019
1	ATA protocolIBA 09/2018
1	Tuberculin (PPD)IBA 09/2018
1	Hair DyesIBA 09/2018
1	4-phenylenediamine (p-phenylenediamine)FDA Link 09/2018
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2016
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 09/2016
1	Parathyroid Hormone (Parathormone)IBA 11/2015
1	EmollientsIBA 02/2013
1	Narcotic Antagonists (Opioid Antagonists)IBA 09/2012
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 06/2011
1	Bombesin Receptors (Bombesin Receptor)IBA 06/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2011
1	Calcium-Binding ProteinsIBA 02/2010
1	alpha-2-HS-GlycoproteinIBA 02/2010
1	Colloids (Colloid)IBA 09/2009
1	citral (neral)IBA 06/2009
1	sorbitan sesquioleateIBA 06/2009
1	hydroxyisohexyl 3-cyclohexene carboxaldehydeIBA 06/2009
1	FarnesolIBA 06/2009
1	Epoxy Resins FDA Link 06/2009
1	geraniol (nerol)IBA 06/2009
1	citronellolIBA 06/2009
1	hydroxycitronellalIBA 06/2009
1	lilialIBA 06/2009
1	ChromatesIBA 04/2009
1	Potassium Dichromate FDA Link 04/2009
1	MetalsIBA 04/2009
1	Menthol FDA Link 01/2009
1	Sulfates (Sulfates, Inorganic)IBA 05/2008
1	Gabapentin (Neurontin)FDA LinkGeneric 03/2008
1	Analgesics (Analgesic Drugs)IBA 03/2008
1	Paroxetine (Paxil)FDA LinkGeneric 01/2008
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2008
1	Immunologic Factors (Immunomodulators)IBA 01/2008

Therapy/Procedure

27	Therapeutics 09/2023 - 02/2003
3	Skin Care 06/2023 - 08/2007
2	Phototherapy (Light Therapy) 04/2019 - 09/2005
2	Secondary Prevention 03/2009 - 01/2005
1	Protective Gloves 06/2023
1	Massage (Zone Therapy) 01/2023
1	Polypharmacy 01/2011
1	Inappropriate Prescribing 08/2009
1	Critical Care (Surgical Intensive Care) 11/2008